Abstract
Coagulase-negative Staphylococci, including Staphylococcus epidermidis, are common pathogens in orthopedic prosthesis infections. Operation and prolonged treatment with rifampicin in combination with another antibiotic is often required. Coagulase-negative Staph-ylococci are frequently multi-resistant, but resistance to vancomycin is rare in Sweden. Linezolid is an alternative, however it is only recommended for up to 4 weeks treatment due to risk of hematological side effects. We have successfully used prolonged treatment with linezolid and rifampicin in a patient suffering from a complicated prosthetic joint infection caused by a vancomycin resistant Staphyloccous epidermidis strain.
MeSH terms
-
Acetamides / administration & dosage
-
Acetamides / pharmacology
-
Acetamides / therapeutic use
-
Anti-Bacterial Agents* / administration & dosage
-
Anti-Bacterial Agents* / pharmacology
-
Anti-Bacterial Agents* / therapeutic use
-
Humans
-
Knee Prosthesis / adverse effects
-
Linezolid
-
Male
-
Middle Aged
-
Oxazolidinones / administration & dosage
-
Oxazolidinones / pharmacology
-
Oxazolidinones / therapeutic use
-
Prosthesis-Related Infections / drug therapy*
-
Prosthesis-Related Infections / microbiology
-
Rifampin / administration & dosage
-
Rifampin / pharmacology
-
Rifampin / therapeutic use
-
Staphylococcal Infections / drug therapy*
-
Staphylococcus epidermidis / drug effects*
-
Staphylococcus epidermidis / isolation & purification
-
Treatment Outcome
-
Vancomycin / administration & dosage
-
Vancomycin / pharmacology
-
Vancomycin / therapeutic use
-
Vancomycin Resistance*
Substances
-
Acetamides
-
Anti-Bacterial Agents
-
Oxazolidinones
-
Vancomycin
-
Linezolid
-
Rifampin